The murine Tcl1 oncogene: embryonic and lymphoid cell expression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Nonrandom chromosomal rearrangements in human leukemias and lymphomas promote malignancy by altering cell growth and survival.
• The TCL1 gene, involved in chromosome translocations in mature T-cell proliferations and chronic lymphocytic leukemias (CLL), is part of a novel gene family.
• Understanding cancer gene function requires appropriate model systems for study and manipulation.

Purpose of the Study:

• To characterize the murine Tcl1 gene and its expression patterns.
• To explore the potential of the murine Tcl1 gene in developing a mouse model for chronic lymphocytic leukemia (CLL).
• To investigate the role of TCL1 in malignant transformation.

Main Methods:

• Sequence analysis and characterization of the murine Tcl1 gene.
• Determination of the chromosomal location of the murine Tcl1 gene (mouse chromosome 12, syntenic to human chromosome 14).
• Analysis of murine Tcl1 gene expression during embryonic development and in various fetal tissues and cell types.

Main Results:

• The murine Tcl1 gene shares sequence similarity with the murine and human MTCP1 gene, both implicated in T-cell leukemias.
• The murine Tcl1 gene is expressed early in mouse embryonic development.
• Expression of the murine Tcl1 gene was detected in fetal hematopoietic organs and in immature T and B lymphocytes.

Conclusions:

• The murine Tcl1 gene is a relevant candidate for studying T-cell malignancies.
• Characterization of the murine Tcl1 gene provides a foundation for developing a mouse model of CLL.
• Further study of the murine Tcl1 gene is essential to decipher its role in malignant transformation and cancer pathogenesis.